Recombinant Human FGF-4, Animal-Free Protein

Catalog #: Qk004 Datasheet / COA / SDS

Catalog #	Availability	Size / Price	Qty
Qk004-0050
Qk004-0500

Recombinant Human FGF-4, Animal-Free Protein Bioactivity

2 Images

Product Details

Reviews

Summary Product Datasheets Carrier Free Data Images Reconstitution Calculator Background Related Research Areas

Recombinant Human FGF-4, Animal-Free Protein Summary

Product Specifications

Endotoxin Level

<0.10 EU per 1 μg of the protein by the LAL method.

Activity

No significant difference between EC₅₀ of reference and test lots

Source

E. coli-derived human FGF-4 protein

Accession #

P08620.1

Predicted Molecular Mass

14 kDa

SDS-PAGE

Monomeric FGF-4 protein only

Product Datasheets

QK004

Product Datasheet

COA

SDS

Carrier Free

What does CF mean?

CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.

What formulation is right for me?

In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.

Qk004

Formulation	Lyophilized from HEPES/NaCl/mannitol
Reconstitution	Resuspend in water at >100 µg/ml, prepare single use aliquots, add carrier protein if desired.
Shipping	The product is shipped lyophilized at ambient temperature, on ice blocks or on dryice. Shipping at ambient temperature does not affect the bioactivity or stability ofthe protein. Upon receipt, store immediately at the conditions stated below.
Stability & Storage:	Store lyophilized protein between -20 °C and -80 °C until the date of expiry. Avoid freeze-thaw cycles.

Scientific Data

Bioactivity

View Larger

Recombinant HumanFGF-4, Animal-Free activity is determined using the firefly luciferase reporter assay (*) in stably transfected HEK293T cells. Cells are treated in triplicate with a serial dilution of FGF-4. Firefly luciferase activity is measured and normalized. EC₅₀ = 4.3 ng/mL (306.5 pM). *Promega pGL4.33[luc2P/SRE/Hygro] #E1340

SDS-PAGE

View Larger

Recombinant human FGF-4 (Catalog # Qk004) migrates as a single band at 14 kDa in non-reducing conditions (NR) and upon reduction (R). No contaminating protein bands are visible.Purified recombinant protein (7 µg) was resolved using 15% w/v SDS-PAGE in reduced (+ beta -mercaptothanol, R) and non-reduced conditions (NR) and stained with Coomassie Brilliant Blue R250.

Reconstitution Calculator

Background: FGF-4

FGF‑4 (fibroblast growth factor‑4), also known as FGF-K or K‑FGF (Kaposi’s sarcoma-associated FGF), is a 25 kDa secreted, heparin‑binding member of the FGF family (1, 2). The human FGF‑4 cDNA encodes 206 amino acids (aa) with a 33 aa signal sequence and a 173 aa mature protein with an FGF homology domain that contains a heparin binding region near the C‑terminus (2). Mature human FGF‑4 (aa 71‑206) shares 91%, 82%, 94% and 91% aa identity with mouse, rat, canine and bovine FGF‑4, respectively. Human FGF‑4 has been shown to exhibit cross species activity. Expression of FGF-4 and its receptors, FGF R1c, 2c, 3c and 4, is spatially and temporally regulated during embryonic development (1, 3). Its expression in the mouse trophoblast inner cell mass promotes expression of FGF R2, and is required for maintenance of the trophectoderm and primitive endoderm (3‑5). Later in mouse development, FGF‑4 works together with FGF‑8 to mediate the activities of the apical ectodermal ridge, which direct the outgrowth and patterning of vertebrate limbs (3, 6‑9). FGF-4 is proposed to play a physiologically relevant role in human embryonic stem cell self-renewal. It promotes stem cell proliferation, but may also aid differentiation depending on context and concentration, and is often included in embryonic stem cell media in vitro (10‑12). A C‑terminally truncated 15 kDa isoform that opposes full‑length FGF‑4 and promotes differentiation is endogenously expressed in human embryonic stem cells. FGF‑4 is mitogenic for fibroblasts and endothelial cells in vitro and has autocrine transforming potential (13). It is a potent angiogenesis promoter in vivo and has been investigated as therapy for coronary artery disease (14).

References

Reuss, B. and O. von Bohlen und Halbach (2003) Cell Tiss. Res. 313:139.
Hebert, J.M. et al. (1990) Dev. Biol. 138:454.
Niswander, L. and G.R. Martin (1992) Development 114:755.
Feldman, B. et al. (1995) Science 267:246.
Goldin, S.N. and V.E. Papaioannou (2003) Genesis 36:40.
Sun, X. et al. (2002) Nature 418:501.
Boulet, A.M. et al. (2004) Dev. Biol. 273:361.
Yu, K and D.M. Ornitz (2008) Development 135:483.
Mariani, F.V. et al. (2008) Nature 453:401.
Johannesson, M. et al. (2009) PLoS ONE 4:e4794.
Kunath, T. et al. (2007) Development 134:2895.
Mayshar, Y. et al. (2008) Stem Cells 26:767.
Hajitou, A. et al. (1998) Oncogene 17:2059.
Flynn, A. and T. O’Brien (2008) IDrugs 11:283.

Long Name

Fibroblast Growth Factor 4

Entrez Gene IDs

2249 (Human); 14175 (Mouse); 116499 (Rat)

Alternate Names

FGF4; FGF-4; fibroblast growth factor 4; HBGF-4; HBGF-4Transforming protein KS3; heparin secretory transforming protein 1; Heparin secretory-transforming protein 1; Heparin-binding growth factor 4; HST-1; HST-1HSTF-1; HSTF1fibroblast growth factor 4 splice isoform; HSTFGF-4; human stomach cancer, transforming factor from FGF-related oncogene; kaposi sarcoma oncogene; KFGF; K-FGF; KS3; oncogene HST

Product Specific Notices

The above product was manufactured, tested and released by R&D System's contract manufacturer, Qkine Ltd, at 1 Murdoch House, Cambridge, UK, CB5 8HW. The product is for research use only and not for the diagnostic or theraputic use.